Literature DB >> 7512487

Lowering blood pressure. How far, how fast?

A Roca-Cusachs1.   

Abstract

There is a general consensus that high blood pressure (BP) must be lowered gradually. A reduction in BP beyond the limits of the autoregulatory curve may compromise perfusion of vital organs, resulting in organ ischaemia. However, a reduction in high BP offers protection against cerebral events, and some protection against coronary heart disease. The limited protection against coronary heart disease provided by BP reduction may be partially explained by the so-called 'J-shaped curve': a reduction in diastolic blood pressure below 85 mmHg may lead to a paradoxical increase in coronary events, although this effect is by no means well established. In addition, the incidence of several events associated with cardiovascular disease peaks during morning hours, at a time when some antihypertensive drugs are least effective. This may also explain the limited coronary protection achieved after administration of antihypertensive drugs.

Entities:  

Mesh:

Year:  1993        PMID: 7512487     DOI: 10.2165/00003495-199300462-00004

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  21 in total

1.  Sympathetic-nerve activity during sleep in normal subjects.

Authors:  V K Somers; M E Dyken; A L Mark; F M Abboud
Journal:  N Engl J Med       Date:  1993-02-04       Impact factor: 91.245

2.  Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group.

Authors: 
Journal:  JAMA       Date:  1991-06-26       Impact factor: 56.272

3.  Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators.

Authors:  M A Pfeffer; E Braunwald; L A Moyé; L Basta; E J Brown; T E Cuddy; B R Davis; E M Geltman; S Goldman; G C Flaker
Journal:  N Engl J Med       Date:  1992-09-03       Impact factor: 91.245

4.  Clinical relevance of nighttime blood pressure and of daytime blood pressure variability.

Authors:  P Palatini; M Penzo; A Racioppa; E Zugno; G Guzzardi; M Anaclerio; A C Pessina
Journal:  Arch Intern Med       Date:  1992-09

5.  Circadian variation in vascular tone and its relation to alpha-sympathetic vasoconstrictor activity.

Authors:  J A Panza; S E Epstein; A A Quyyumi
Journal:  N Engl J Med       Date:  1991-10-03       Impact factor: 91.245

6.  Benefits and potential harm of lowering high blood pressure.

Authors:  J M Cruickshank; J M Thorp; F J Zacharias
Journal:  Lancet       Date:  1987-03-14       Impact factor: 79.321

7.  Low mortality from all causes, including myocardial infarction, in well-controlled hypertensives treated with a beta-blocker plus other antihypertensives.

Authors:  J M Cruickshank; K Pennert; A E Sörman; J M Thorp; F M Zacharias; F J Zacharias
Journal:  J Hypertens       Date:  1987-08       Impact factor: 4.844

8.  Relation of low diastolic blood pressure to coronary heart disease death in presence of myocardial infarction: the Framingham Study.

Authors:  R B D'Agostino; A J Belanger; W B Kannel; J M Cruickshank
Journal:  BMJ       Date:  1991-08-17

9.  The Beta-Blocker Pooling Project (BBPP): subgroup findings from randomized trials in post infarction patients. The Beta-Blocker Pooling Project Research Group.

Authors: 
Journal:  Eur Heart J       Date:  1988-01       Impact factor: 29.983

10.  Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias.

Authors:  S MacMahon; R Peto; J Cutler; R Collins; P Sorlie; J Neaton; R Abbott; J Godwin; A Dyer; J Stamler
Journal:  Lancet       Date:  1990-03-31       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.